Pearl River Capital’s National Health Investors NHI Stock Holding History

Pearl River Capital’s Portfolio NHI Stock Details NHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,597	Closed	-$212K	–	655
2019 Q4	$212K	Buy	2,597 +2,589	+32,363%	+$212K	0.08%	466
2019 Q3	$1K	Buy	+8	New	+$651	﹤0.01%	405

Other funds holding NHI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pearl River Capital's NHI Position: Q1 2020 in Review

Pearl River Capital sold out of National Health Investors (NHI) in Q1 2020, closing a stake of 2,597 shares — an estimated $212K sold.

Pearl River Capital first reported a position in NHI in Q3 2019 and held it in 2 quarters. The position peaked at $212K in Q4 2019. 245 funds tracked by Wall St. Rank hold NHI as of Q1 2020.

Pearl River Capital reported no remaining National Health Investors position as of Q1 2020 after selling out during the quarter.
Pearl River Capital sold 2,597 National Health Investors shares in Q1 2020, an estimated $212K.
Pearl River Capital first reported a position in National Health Investors in Q3 2019 and held it in 2 quarters.
Pearl River Capital's National Health Investors position peaked at $212K in Q4 2019.
245 funds tracked by Wall St. Rank held National Health Investors as of Q1 2020.

Based on Pearl River Capital's 13F filing for Q1 2020, filed 6 May 2020.